Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × amivantamab × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 12 OTHER 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 38 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 23 Radiation 20 Vincristine 19 Cisplatin 19 Carboplatin 17 Radiotherapy 15 Etoposide 15 Biopsy 13 Irinotecan 11 Doxorubicin 11 Dexamethasone 11 Methotrexate 10 Radiotherapy, Intensity-Modulated 9 Platinum 9 Leucovorin 9 Gemcitabine 9 Cytarabine 9 1,2-diaminocyclohexaneplatinum II citrate 9 fludarabine 8 Stem Cell Transplantation 8 Observation 8 Fluorouracil 8 merphos 7 dehydroftorafur 7 daratumumab 7 X-Rays 7 Surgical Procedures, Operative 7 Spinal Puncture 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05601973 2026-01-21

AMAZE-lung

ETOP IBCSG Partners Foundation

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡